CBSET Inc. is a state-of-the-art preclinical translational research institute dedicated to the advancement of early-stage biomedical technologies. CBSET’s mission is to help our sponsors develop unique tools and novel methods to promote early diagnosis and develop innovative treatments for complex diseases. CBSET specializes in the development and application of novel minimally invasive techniques in the fields of cardiology, endoscopy, surgery, drug and device delivery, drug and device safety, and diagnostic imaging.